Results 151 to 160 of about 55,959 (291)
Abstract Background Territory‐wide epidemiological studies of acute Chinese medicine poisoning involving aconite after 2010 are lacking. Objectives To characterise the latest trends, presumed causes, clinical presentations, healthcare utilisation and patient outcomes of such poisoning cases in Hong Kong.
Rex Pui Kin Lam +9 more
wiley +1 more source
Tailored Core‐Shell Nanocarrier for Therapeutic Drug Delivery via Visible Light Activation
A core‐shell nanocarrier activated by visible light, composed of poly(3‐octylthiophene‐2,5‐diyl) (POT), iron oxide (II, III) (Fe3O4), polyvinyl alcohol (PVA), and trazodone tetraphenylborate (TRZ+ TPB−). During POT photooxidation (POT+), TRZ+ is liberated driven by the maintenance of particle's electroneutrality.
Deric Andrade‐Alarcón +3 more
wiley +2 more sources
Prolongation of QT Interval in ECG: A Hidden Complication of Cirrhotic Liver Disease
Ajeet Kumar +5 more
openalex +2 more sources
Abstract Purpose Extensor mechanism (EM) ruptures after total knee arthroplasty (TKA) are rare but lead to substantial functional impairment and morbidity. Treatment remains challenging due to the diversity of surgical techniques and the limited number of comparative studies.
Bruno Violante +12 more
wiley +1 more source
Syncope with QT-interval prolongation and T-wave inversion in anterior and inferior leads: Foreboder of a life-threatening condition? [PDF]
Li JX, Wang J, Li XQ, Gao M.
europepmc +1 more source
Natural Products in Cancer Prevention and Therapy: Current Challenges and Future Directions
Natural products play a pivotal role in cancer therapy. They induce cancer cell death by reprogramming four metabolic pathways while precisely targeting the tumor microenvironment and immune cells. These compounds not only leverage novel delivery systems for innovative applications but also demonstrate unique therapeutic efficacy across clinical stages:
Ruimiao Qian +8 more
wiley +1 more source
Clinical-pharmacological aspects of the safe use of medicines, causing prolongation of QT interval
Specific aspects of manifestation of prolonged QT syndrome, developed during the use of drugs belonging to different pharmacological groups are discussed. It analyses data on dangerous combinations of drugs that prolong the QT interval.
O. A. Demidova +3 more
doaj
ABSTRACT Given the high prevalence of the population who have metabolic dysfunction‐associated steatohepatitis (MASH), interest is growing in MASH‐targeted treatments. However, currently, there has been only one regulatory approved drug for MASH (Rezdiffra).
Quyen Thi Tran +11 more
wiley +1 more source

